Christine Baeder, President of Apotex USA, Alfred Engelberg, a retired attorney with a focus on the generic pharmaceutical industry, and Jeremy Greene, a professor at Johns Hopkins, dive into the rising costs of life-saving medications. They discuss the emotional toll on patients facing exorbitant prices and the struggles generics face against patent-holding brand companies. The conversation also covers the implications of recent reforms like the Inflation Reduction Act and the ongoing challenges of ensuring affordable medication access for all.
